X4 Pharmaceuticals, Inc — Director's Dealing 2020

Dec 28, 2020

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: X4 Pharmaceuticals, Inc (XFOR)
CIK: 0001501697
Period of Report: 2020-12-23

Reporting Person: Ragan Paula (Director, President and CEO)

Non-Derivative Transactions

Date	Security	Code	Shares	Price	A/D	Holdings After	Ownership
2020-12-23	Common Stock	S	4800	$7	Disposed	280123	Direct

Footnotes

F1: The reported transaction was effected pursuant to a Rule 10b5-1 trading plan.

F2: Of the shares of common stock reported, 101,714 shares represent unvested restricted stock units.